세계의 약물 용출 스텐트 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 코팅 유형별(폴리머 기반 코팅, 폴리머 프리 코팅), 용도별, 지역별, 경쟁별(2020-2030년)

Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Coating Type (Polymer-based Coatings, Polymer-free Coatings), By Application, By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,385,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,805,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,352,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

약물 용출 스텐트(DES) 세계 시장 규모는 2024년 83억 달러로 평가되었고, 2030년까지 8.08%의 연평균 복합 성장률(CAGR)로 견조한 성장이 예상됩니다.

세계 헬스케어 분야, 특히 기술 및 혁신 분야의 큰 발전은 환자 치료와 치료 결과를 개선하는 데 중요한 역할을 하고 있습니다. 이러한 발전 속에서 약물 용출 스텐트는 중재적 심장학 분야의 혁신적인 솔루션으로 등장했습니다. 이 작지만 중요한 의료기기는 관상동맥질환(CAD) 관리에 혁명을 가져왔으며, 전 세계 DES 시장의 괄목할 만한 성장을 견인하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	83억 달러
시장 규모 : 2030년	132억 6,000만 달러
CAGR : 2025-2030년	8.08%
급성장 부문	폴리머 베이스 코팅
최대 시장	북미

약물 용출 스텐트는 관상동맥 질환을 치료하고 동맥 재협착의 가능성을 줄이기 위해 사용되는 특수 의료기기입니다. 항재협착제로 코팅된 금속 메쉬 튜브로 구성된 DES는 동맥의 개통성을 유지하는 구조적 지지체로서의 기능과 약물을 제어적으로 방출하는 전달 시스템으로서의 기능을 겸비하고 있습니다. 이 두 가지 기능을 통해 협착 또는 폐색된 관상동맥에 DES를 삽입한 후 재협착을 방지할 수 있습니다.

주요 시장 성장 촉진요인

세계 인구의 고령화

주요 시장 과제

규제상의 장애물

주요 시장 동향

기술 발전

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 약물 용출 스텐트 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 코팅 유형별(폴리머 기반 코팅(비생분해성, 생분해성), 폴리머 프리 코팅(마이크로 포러스 표면, 마이크로 구조 표면, 슬롯 관 모양 표면, 나노 포러스 표면))
  • 용도별(관상동맥 질환, 말초동맥 질환)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 약물 용출 스텐트 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 약물 용출 스텐트 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 약물 용출 스텐트 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 약물 용출 스텐트 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 약물 용출 스텐트 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제13장 세계의 약물 용출 스텐트 시장 : SWOT 분석

제14장 경쟁 구도

• Abbott Laboratories Ltd.
• Boston Scientific Corporation
• Terumo Corporation
• Medtronic plc
• Biosensors International Ltd
• Cook Medical pvt ltd.
• B. Braun Medical(India) Private Limited
• Biotronik, Inc.
• Lepu Medical Technology Inc.

제15장 전략적 제안

제16장 회사 소개 및 면책조항

LSH

영문 목차

영문목차

Global Drug-eluting stent (DES) market was valued at USD 8.30 billion in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 8.08% through 2030. Significant advancements within the global healthcare sector-particularly in technology and innovation-have played a critical role in enhancing patient care and treatment outcomes. Among these advancements, drug-eluting stents have emerged as a transformative solution in interventional cardiology. These small yet vital medical devices are revolutionizing the management of coronary artery disease (CAD), thereby fueling notable expansion in the global DES market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 8.30 Billion
Market Size 2030	USD 13.26 Billion
CAGR 2025-2030	8.08%
Fastest Growing Segment	Polymer-based Coatings
Largest Market	North America

Drug-eluting stents are specialized medical devices used to treat coronary artery disease and reduce the likelihood of arterial re-narrowing. Comprising a metallic mesh tube coated with an anti-restenotic drug, DES function both as a structural support to maintain arterial patency and as a delivery system for controlled drug release. This dual function helps prevent restenosis following implantation in narrowed or blocked coronary arteries..

Key Market Drivers

Aging Global Population

The growing elderly population is a major driver of the DES market, as older individuals are more vulnerable to cardiovascular diseases, particularly CAD. With global life expectancy on the rise, demand for minimally invasive cardiac treatments is expected to increase. According to the World Health Organization, the global population aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion by 2030 and reach 2.1 billion by 2050. The 80+ age group is also set to triple, rising to 426 million by 2050. This demographic shift has far-reaching implications for healthcare providers and device manufacturers, as cardiovascular treatments such as DES become increasingly essential.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges for the DES market is the constantly evolving regulatory landscape. Regulatory bodies across various regions frequently revise guidelines governing medical devices. As a result, manufacturers must allocate significant resources to ensure ongoing compliance. Securing approvals for new or modified products can be both time-intensive and costly, potentially delaying market entry and impacting profitability.

Key Market Trends

Technological Advancements

Technological innovation is significantly reshaping the global healthcare landscape, with drug-eluting stents at the forefront of progress in interventional cardiology. One of the most notable advancements is the use of biocompatible polymers that optimize drug release kinetics and reduce adverse patient reactions such as inflammation or allergies.

In addition, bioabsorbable stents represent a cutting-edge development. Designed to gradually dissolve within the body, these stents eliminate the long-term complications often associated with permanent metal implants, such as late-stage thrombosis. These innovations are expected to enhance treatment outcomes and further stimulate market growth in the coming years.

Key Market Players

• Abbott Laboratories ltd.
• Boston Scientific Corporation
• Terumo Corporation
• Medtronic plc
• Biosensors International Ltd
• Cook Medical pvt ltd.
• B. Braun Medical (India) Private Limited
• Biotronik, Inc.
• Lepu Medical Technology Inc.

Report Scope:

In this report, the Global Drug Eluting Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Eluting Stent Market, By Coating Type:

• Polymer-based Coatings
• Polymer-free Coatings

Drug Eluting Stent Market, By Application:

• Coronary Artery Disease
• Peripheral Artery Disease

Drug Eluting Stent Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Eluting Stent Market.

Available Customizations:

Global Drug Eluting Stent market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Drug Eluting Stent Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings (Micro porous Surface, Micro structured Surface, Slotted tubular Surface, Nanoporous Surface))
  • 5.2.2. By Application (Coronary Artery Disease, Peripheral Artery Disease)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Drug Eluting Stent Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Coating Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Drug Eluting Stent Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Coating Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Drug Eluting Stent Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Coating Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Drug Eluting Stent Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Coating Type
      • 6.3.3.2.2. By Application

7. Europe Drug Eluting Stent Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Coating Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Drug Eluting Stent Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Coating Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Drug Eluting Stent Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Coating Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Drug Eluting Stent Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Coating Type
      • 7.3.3.2.2. By Application
  • 7.3.4. France Drug Eluting Stent Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Coating Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Drug Eluting Stent Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Coating Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Drug Eluting Stent Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Coating Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Drug Eluting Stent Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Coating Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Drug Eluting Stent Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Coating Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Drug Eluting Stent Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Coating Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Drug Eluting Stent Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Coating Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Drug Eluting Stent Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Coating Type
      • 8.3.5.2.2. By Application

9. South America Drug Eluting Stent Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Coating Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Drug Eluting Stent Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Coating Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Drug Eluting Stent Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Coating Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Drug Eluting Stent Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Coating Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Drug Eluting Stent Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Coating Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Drug Eluting Stent Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Coating Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Drug Eluting Stent Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Coating Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Drug Eluting Stent Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Coating Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Drug Eluting Stent Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Ltd.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Boston Scientific Corporation
• 14.3. Terumo Corporation
• 14.4. Medtronic plc
• 14.5. Biosensors International Ltd
• 14.6. Cook Medical pvt ltd.
• 14.7. B. Braun Medical (India) Private Limited
• 14.8. Biotronik, Inc.
• 14.9. Lepu Medical Technology Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료